Alcami Overview

  • Year Founded
  • 1979

Year Founded

  • Status
  • Private

  • Employees
  • 1,050

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 10

  • Investments
  • 5

Alcami General Information

Description

Operator of contract development and manufacturing organization (CDMO) intended for small and mid-sized pharmaceutical and biotechnology companies. The company offers formulation and analytical development, testing, microbial identification, stability storage, and other laboratory-related services, enabling clients to avail of a less-fragmented, cost-effective, and faster pathway for product commercialization.

Contact Information

Website
www.alcami.com
Formerly Known As
Cambridge Major Laboratories
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 2320 Scientific Park Drive
  • Wilmington, NC 28405
  • United States
+1 (800)
Primary Industry
BPO/Outsource Services
Other Industries
Pharmaceuticals
Drug Discovery
Vertical(s)
Manufacturing
Corporate Office
  • 2320 Scientific Park Drive
  • Wilmington, NC 28405
  • United States
+1 (800)

Alcami Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alcami Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Alcami‘s full profile, request access.

Request a free trial

Alcami Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of contract development and manufacturing organization (CDMO) intended for small and mid-sized pharmaceutical a
BPO/Outsource Services
Wilmington, NC
1,050 As of 2024

Stockholm, Sweden
 

Clearwater, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alcami Competitors (20)

One of Alcami’s 20 competitors is Recipharm, a Private Equity-Backed company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Recipharm Private Equity-Backed Stockholm, Sweden
CoreRx Private Equity-Backed Clearwater, FL
Catalent Private Equity-Backed NJ
Curia Private Equity-Backed Albany, NY
Pnp Pharmaceuticals Private Equity-Backed Burnaby, Canada
You’re viewing 5 of 20 competitors. Get the full list »

Alcami Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Alcami Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11642324-B1 Topical tranexamic acid compositions and methods of use thereof Active 01-Mar-2022
US-20240415794-A1 Topical tranexamic acid compositions and methods of use thereof Pending 01-Mar-2022
US-20220227692-A1 Compositions and methods of making ribitol Active 28-May-2019
US-12252463-B2 Compositions and methods of making ribitol Active 28-May-2019
US-20220033352-A1 Synthetic method for the preparation of an alkoxymethylene-benzoylacetonitrile Inactive 26-Sep-2018 C07C253/30
To view Alcami’s complete patent history, request access »

Alcami Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alcami Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Alcami‘s full profile, request access.

Request a free trial

Alcami Investments (5)

Alcami’s most recent deal was a Buyout/LBO with Pacific Pharmaceutical Services. The deal was made on 17-Jan-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pacific Pharmaceutical Services 17-Jan-2024 Buyout/LBO Logistics
Masy Bioservices 15-Dec-2021 Buyout/LBO Laboratory Services (Healthcare)
TriPharm Services 17-Jan-2020 Buyout/LBO Other Pharmaceuticals and Biotechnology
aaiPharma Inc 02-Oct-2013 Buyout/LBO Other Pharmaceuticals and Biotechnology
Cambridge Major Laboratories Europe 16-Nov-2007 Buyout/LBO Pharmaceuticals
To view Alcami’s complete investments history, request access »

Alcami Exits (1)

Alcami’s most recent exit was on 16-Nov-2007 from Cambridge Major Laboratories Europe. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Cambridge Major Laboratories Europe 16-Nov-2007 Completed
  • 2 buyers
To view Alcami’s complete exits history, request access »

Alcami Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Pacific Pharmaceutical Services Reno, NV 2009
TriPharm Services Morrisville, NC 1994

Alcami FAQs

  • When was Alcami founded?

    Alcami was founded in 1979.

  • Where is Alcami headquartered?

    Alcami is headquartered in Wilmington, NC.

  • What is the size of Alcami?

    Alcami has 1,050 total employees.

  • What industry is Alcami in?

    Alcami’s primary industry is BPO/Outsource Services.

  • Is Alcami a private or public company?

    Alcami is a Private company.

  • What is Alcami’s current revenue?

    The current revenue for Alcami is .

  • How much funding has Alcami raised over time?

    Alcami has raised $161M.

  • Who are Alcami’s investors?

    GHO Capital, Vistria Group, and Ampersand (Massachusetts) have invested in Alcami.

  • Who are Alcami’s competitors?

    Recipharm, CoreRx, Catalent, Curia, and Pnp Pharmaceuticals are some of the 20 competitors of Alcami.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »